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Abstract
Background: Like other countries in Asia, measles-rubella (MR) vaccine coverage in Bangladesh is suboptimal
whereas 90–95 % coverage is needed for elimination of these diseases. The Ministry of Health and Family Welfare
(MOHFW) of the Government of Bangladesh implemented MR campaign in January-February 2014 to increase
MR vaccination coverage. Strategically, the MOHFW used both routine immunization centres and educational
institutions for providing vaccine to the children aged 9 months to <15 years. The evaluation was carried out to
assess the impact of the campaign on MR vaccination and routine immunization services.
Methods: Both quantitative and qualitative evaluations were done before and after implementation of the
campaign. Quantitative data were presented with mean (standard deviation, SD) for continuous variables and with
proportion for categorical variables. The overall and age- and sex-specific coverage rates were calculated for each
region and then combined. Categorical variables were compared by chi-square statistics. Multiple logistic regression
analysis were performed to estimate odds ratios (OR) and 95 % confidence intervals (CI) of coverage associated
with covariates, with adjustment for other covariates. Qualitative data were analyzed using content analysis.
Results: The evaluations found MR coverage was very low (<13 %) before the campaign and it rose to 90 % after
the campaign. The pre-post campaign difference in MR coverage in each stratum was highly significant (p < 0.001).
The campaign achieved high coverage despite relatively low level (23 %) of interpersonal communication with
caregivers through registration process. Child registration was associated with higher MR coverage (OR 2.91,
95 % CI 1.91–4.44). Children who attended school were more likely to be vaccinated (OR 8.97, 95 % CI 6.17–13.04)
compared to those who did not attend school. Children of caregivers with primary or secondary or higher
education had higher coverage compared to children of caregivers with no formal education. Most caregivers
mentioned contribution of the campaign in vaccination for the children not previously vaccinated.
Conclusions: The results of the evaluation indicated that the campaign was successful in terms of improving MR
coverage and routine immunization services. The evaluation provided an important guideline for future evaluation
of similar efforts in Bangladesh and elsewhere.
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Background
Measles and rubella are among the most infectious dis-
eases of humans. High level of herd immunity is re-
quired for its elimination [1]. Seroprevalence studies
suggest that coverage in the range of 90–95 % is needed
[2]. Measles and rubella are vaccine-preventable diseases
with similar symptoms and are frequently confused with
each other. Both viruses cause rash and fever [3]. Mea-
sles can be deadly for children with poor nutrition and
weakened immune systems. Rubella is also very conta-
gious but causes relatively mild disease in children; in
pregnant women, rubella can lead to miscarriage or se-
vere birth defects (congenital rubella syndrome), includ-
ing blindness, deafness, and heart problems [4]. Rubella
and measles are a public health problem in poor coun-
tries in Africa and Asia, including Bangladesh, where up-
take of the measles and rubella vaccine is relatively low
and increasing access to immunization through large-
scale vaccination campaigns can significantly reduce
deaths and illnesses [5].
By the end of 2009, all WHO regions achieved either
measles-rubella control or elimination goals [3]. Pan
American Health Organization (PAHO) and European
Regional Office (EURO) instituted combined measles
and rubella elimination goals. In the PAHO region, it is
believed that this elimination goal has been achieved,
and a certification committee has been formed. In re-
gions under Western Pacific Regional Office (WPRO),
the goal was to eliminate measles by 2012. African
Regional Office (AFRO) adopted a pre-elimination goal
in 2008, which was very close to elimination. South East
Asian Regional Office (SEARO) has recently transitioned
from a mortality reduction goal to an elimination goal.
Like other countries in Asia, measles-rubella (MR)
vaccine coverage in Bangladesh is suboptimal [6]. In
2011, the routine surveillance system detected sero-
logical and expanded programme on immunization
(EPI)-linked rubella incidence in Bangladesh among 37
per million individuals. The previous year–2010–had an
epidemic and a rubella incidence rate of 87 per million
individuals. The objective of vaccination of <15 children
is to elimination of MR. Around 80 % of the measles
and rubella cases were less than 15 years of age in 2011
[7]. The finding suggests that national-level MR cam-
paign covering children with aged 9 months to <15 years
may substantially increase the coverage and reduce both
rubella and measles virus circulation and enable to
achieve measles and rubella elimination goal.
Measles vaccination campaigns were undertaken in
Bangladesh in 2005, 2006, and 2010 to boost measles
vaccination coverage. According to the reports, the rou-
tine measles coverage increased from below 60 % to
above 80 % after the 2005–2006 measles campaign. The
post- campaign survey conducted in 2010, reported that
the campaign had improved measles coverage [8]. The im-
pact evaluations of those campaigns were not very system-
atic in terms of assessment of workload, effects of the
campaign on activities of routine EPI and other health sys-
tems. The target population of previous measles cam-
paigns was very narrow-children aged 9–12 months
compared to the target population of the MR campaign in
2014 among children aged 9 months to <15 years.
The Gavi Alliance is investing more than US$ 600 million
in the fight against measles and rubella through large-scale
campaigns [9]. The Alliance targets over 700 million
children in 49 countries aged 9 months to 14 years to
immunize against measles-rubella [10]. The Gavi Alliance
supported MR campaign in Bangladesh in 2014 to supple-
ment the introduction of routine MR vaccination [11]. The
Ministry of Health and Family Welfare (MOHFW) of the
Government of Bangladesh (GoB) implemented the MR
campaign nationally in January-February 2014 targeting
more than 52 million children aged 9 months to <15 years
[12] to increase MR vaccine coverage. Schools and other
educational institutions and routine EPI centres were used
for sessions on MR vaccination. Students remained absent
at school during campaign were vaccinated at routine
immunization outreach centers. The campaign was con-
ducted nationally and, to date, is the largest MR campaign
conducted globally. To guide continued measles and ru-
bella elimination activities, an effective evaluation of the
2014 MR campaign was critical. This article highlighted the
impact of the MR campaign on improving MR vaccine
coverage and on the routine EPI in Bangladesh.
Methods
Mixed method approaches were employed at various
levels of the health system of Bangladesh. Assessments
were conducted in 2013 before the MR campaign and in
2014 after the campaign.
Study areas
The evaluation focused on selected locations stratified by
urban/rural and low/high performing areas. The post-
campaign survey was nationally representative. Bangladesh
is divided into seven administrative divisions (regions).
These divisions consist of 64 districts, which are further
subdivided into 485 upazillas (sub-districts). We had pur-
posively selected two divisions, one high performing
(namely Rajshahi) and one low performing (namely
Sylhet), from the seven divisions for pre campaign evalu-
ation. Rajshahi is in the western part, and Sylhet in the
northeastern part of Bangladesh. From the two divisions
we selected one rural district and one urban city cor-
poration each. In Rajshahi Division, the rural district is
Joypurhat and the urban city corporation is Rajshahi City
Corporation. According to the annual coverage evaluation
survey (CES) 2011, Joypurhat district and Rajshahi City
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Corporation have the highest EPI coverage within their
division. In the Sylhet division, Sylhet district and Sylhet
City Corporation have the lowest EPI coverage within
their division. Thus, we selected the highest performing
Joypurhat district and Rajshahi city, and the lowest per-
forming Sylhet district and Sylhet City.
Sampling
We conducted separate coverage surveys both pre and
post campaign. Pre-and-post-campaign surveys were
necessary to understand how population-level vaccine
coverage had changed as a result of the campaign.
To minimize costs of conducting the survey work for
the pre-campaign survey we focused on four geographies
divided between urban/rural and high performing/low
performing areas. As stated, the post campaign survey
was nationally representative so that population-level
vaccine coverage could be estimated. We purposefully
sampled the same geographies included in the pre-
campaign survey to allow measurement of change in
vaccine coverage as a result of the campaign.
Sampling frame for pre-campaign survey
Since selection of locations were intentional based on
administrative results, population denominator was ad-
justed applying the appropriate sampling rate. Each sub-
district is divided into unions and each union into 24
EPI clusters, each of around 200 households (or 1000
population). The list of EPI clusters is quite complete
and up-to-date, and is available at the sub-district EPI
offices. This list served as the sampling frame for the
first stage of selection of EPI clusters in each stratum.
In total 1,735 households were sampled in the pre-
campaign survey. A stratified two-stage random cluster
sampling design was followed to minimize travel costs and
time and to ease supervision. The first stage was the ran-
dom selection of EPI clusters, and the second stage was se-
lection of households with eligible children. The Coverage
Evaluation Survey (CES) commissioned by MOHFW to a
third party every year provides estimates of EPI coverage
by antigen at division and district levels, and cities separ-
ately. The CES estimates were used to identify two rural
districts—namely Joypurhat and Sylhet (excluding the city),
and two cities—Rajshahi and Sylhet with the highest and
the lowest EPI coverage in the respective divisions. The
minimum required sample size was estimated for each
stratum in order to obtain statistical significance of differ-
ence in MR coverage 10 % points or more between the
pre- and post-campaign surveys at p = 5 % with 80 %
power of the test.
Sampling framework for post campaign survey
The post campaign survey was designed to nationally rep-
resentative, and to provide sub-national (administrative
division) estimates. Our post-campaign survey estimates
allowed us to compare with the pre-campaign survey esti-
mates to assess the change in measles and rubella vaccine
coverage due to the MR campaign. The total sample size
of the post-campaign survey was 4,510.
Data collection
Following techniques were used for data collection for
the evaluation:
Pre and post-campaign surveys
Before implementation of the MR campaign, a survey
was conducted with the primary caregiver of children
aged 9 months to < 15 years. Also after the MR cam-
paign was completed, we conducted a post-campaign
survey, using the same procedure as pre-campaign sur-
vey. Data included: status of MR vaccination among chil-
dren, key demographic and household socio-economic
status (SES) data, demand-side constraints and percep-
tions about the campaign.
Qualitative technique
Key informant interviews
A total of 58 purposively selected key informant inter-
views (KIIs) were conducted after the MR campaign,
following coverage surveys at the national, district, and
facility levels. Issues explored through KII include:
human resource and workload, demand generation, and
supply of vaccine and other related commodities supply.
We sampled key informants from national, district and
sub-district levels.
Data analysis
In the post-campaign survey, probability of selection of
the EPI centres at division level and the probability of
successful interview at cluster level within divisions var-
ied, as such sampling weights (reciprocal of the selection
probability) were estimated to compute weighted cover-
age rates for each division and all divisions combined.
Data were presented with mean (standard deviation, SD)
for continuous variables and with proportion for cat-
egorical variables. The overall and age- and sex-specific
coverage rates were calculated for each division and then
combined. Categorical variables were compared by chi-
square statistics. Multiple logistic regression analyses
were performed to estimate odds ratios (OR) and 95 %
confidence intervals (CI) of coverage associated with
covariates, with adjustment for other covariates. Qualita-
tive data were analyzed using content analysis.
Results
Socio-demographic characteristics of respondents
Respondents in the pre- and post campaign surveys were
mostly mothers/female caregivers of children (>98 % in
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rural and in urban areas) with a few exceptions. Majority
of them were aged 25–44 years in each survey. The
mean age of the respondents from the high-performing
division was little lower than that from low-performing
division. The difference in secondary or more education
between the high and the low performing divisions was
larger than the difference between the urban and rural
strata within the divisions.
Impact of MR campaign on MR vaccination coverage
As expected MR coverage, defined as recall of having re-
ceived MR vaccination before and during the campaign,
was very low in each stratum in the pre-campaign sur-
vey, followed by a sharp rise in the post-campaign survey
(Fig. 1). The pre-post difference in MR coverage in each
stratum was highly significant (p < 0.001).
MR coverage by division and age group of children
National MR Coverage in the post-campaign survey was
90 % (95 % CI: .89–.92). Although overall coverage was
high, there were some important differences to highlight
by geography and age group of children. Coverage varied
by division, with Rajshahi having 94 % (95 % CI: .93–.96)
coverage while Sylhet had only 83 % (95 % CI: .83–.88).
The coverage of other divisions were 89 % (95 %
CI: .86–.92) in Barisal, 91 % (95 % CI: .89–.95) in
Chittagong, 89 % (95 % CI: .87–.93) in Dhaka, 90 % (95 %
CI: .86–.93) in Khulna and 94 % (95 % CI: .93–.97) in
Rangpur. The findings revealed that MR coverage was
higher among school going age group (5–14 years)
children compared to non-school going group of children
(Fig. 2).
MR coverage by potential correlates
There were some small, but significant differences in the
MR coverage by child’s and household’s characteristics
(Table 1). The campaign achieved high coverage despite
relatively low level (23 %) of personal communication
with caregivers through the registration process. Child
registration was associated with higher MR coverage
(OR 3.31, 95 % CI 2.37–4.63). Child’s age and sex were
associated with MR coverage. Children who attended
school were more likely to be vaccinated (OR 8.97, 95 %
CI: 6.17–13.04), compared to those who did not attend
school. Children of caregivers with primary or secondary
or higher education had higher coverage compared to
children of caregivers with no formal education. Though
household asset quintile and type of residence were not
associated with coverage but living in an administrative
division was associated with high or low coverage.
Reasons for not vaccinating during MR campaign
In our post-campaign survey, 17 % of primary caregivers
of unvaccinated children did not know about the cam-
paign with some geographic variations (Table 2). This
was higher in Sylhet and Chittagong, where vaccination
coverage was consistent low, than Rangpur, Dhaka and
Khulnar. Around one third of caregivers of unvaccinated
children cited child’s sickness at the time of vaccination
and another one-third cited fear of side effects as rea-
sons for non-vaccination.
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Fig. 1 MR coverage in pre- and post campaign surveys in high and low performing divisions
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Impact of MR campaign on routine EPI
Coverage of measles containing vaccine (MCV) before and
after the campaign
Routine coverage of MCV was increased after the cam-
paign. The increase was the highest from 80 % in the
pre-campaign to 95 % in the post-campaign in rural
stratum of Rajshahi division. On contrary, the increase
was lowest 2 % points in the Rajshahi city. In Sylhet
division, the increases in rural and urban strata were
3 % and 4 % respectively (data not shown). The re-
sults from qualitative component showed that the MR
campaign had positive impact on routine EPI services
in Bangladesh. Followings are the details about this:
Increased public awareness and acceptance Findings
showed that during preparation for MR Campaign, the
GoB was concerned that persistent fears in the popula-
tion about the adverse events and child death from a
Vitamin A provided in the campaign in March 2013
would impact on demand for MR vaccine. Our findings
suggest, however, that the MR campaign helped to re-
shape perceptions. One rural service provider stated:
Our routine EPI coverage was low after the rumor of
Vitamin A plus campaign. The situation changed in the
community after the MR campaign. Specifically, when
people came to the MR campaign sessions, they gained a
better understanding and reduced their misconceptions.
They realized that these vaccines have been introduced
for their welfare. We also mentioned to the guardians
that Vitamin A plus campaign’s adverse news which
were broadcasted were nothing but rumors.
Improved provider-caregiver communication This
campaign improved the communication between service
providers and caregivers during the preparation phase of
the campaign as a result of the door-to-door registration
process. This door-to-door registration process increased
provider-caregiver communication, and had the poten-
tial to improve communication for routine EPI.
Improved logistics During the MR campaign, many
logistics (e.g., vaccine carriers, ice packs, ice lining refrig-
erators, deep freezers, and vehicles) were either repaired
or newly purchased. Although most of these logistics
were very costly, they were critical for preserving the
quality of the vaccines. These logistics would also be
available to the routine EPI program.
Strengthened inter-sectoral coordination In order to
conduct such a large nationwide program, proper coordin-
ation and integration at different levels and across sectors
was required. These lessons learned and experience can be
incorporated in the EPI sector for future immunization
campaigns and large scale health interventions.
Demand on health worker time and implications on
routine activities The MR campaign was designed to
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Fig. 2 MR coverage by administrative division and by age group of children
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minimize interference to routine EPI activities by sched-
uling campaign activities for 5 days of the week with
routine EPI activities for 2 days of the week. It is import-
ant to note that this resulted in a significant increase in
workload for EPI service providers as evidence by the
EPI provider survey conducted. However, findings from
key informant interviews suggest that health workers
were highly motivated to work extra hours.
Catch up immunizations for MR vaccine recipients
Mass immunization campaigns offer an important op-
portunity to catch up or provide booster doses for other
Table 1 Levels and differentials in MR coverage and odds ratioa, b (OR) of MR vaccination for selected covariates in
post-campaign survey
Name of the covariate Number of
children
Coverage
rate (%)
Logistic regression model estimates
Adjusted ORa, b 95 % CI p-value
Child’s registration prior to campaign
Not registered 3401 87.1 1.00 REF
Registered 1096 95.2 3.31 (2.37–4.63) <0.001
Sex of the child
Male 2415 88.0 1.00 REF
Female 2081 90.3 1.21 (0.99–1.48) 0.062
Age of the child
9 months – 4 years 1184 82.3 1.00 REF
5–9 years 1637 92.8 1.91 (1.26–2.89) 0.002
10–14 years 1673 90.0 1.28 (0.78–2.11) 0.324
Child’s school attendance
Did not attended 185 57.8 1.00 REF
Attended 2821 93.7 8.97 (6.17–13.04) <0.001
Minor (aged ≤5 years) 1284 84.1 3.84 (2.28–6.48) <0.001
Mother’s education level
None 1193 84.8 1.00 REF
Primary (up to V) 1581 89.7 1.44 (1.10–1.89) 0.008
Secondary and higher 1723 91.4 1.63 (1.21–2.20) 0.001
Household asset quintile
Lowest 914 87.4 1.00 REF
Second 886 89.6 1.21 (0.88–1.65) 0.233
Middle 901 89.9 1.20 0.85–1.68) 0.300
Fourth 950 90.2 1.23 (0.85–1.80) 0.263
Highest 844 88.0 1.11 (0.84–2.52) 0.184
Administrative division
Barisal 451 89.6 1.00 REF
Chittagong 428 91.4 1.45 (0.84–2.52) 0.184
Dhaka 414 89.4 1.04 (0.65–1.68) 0.862
Khulna 378 89.7 1.09 (0.65–1.82) 0.738
Rajshahi 986 94.2 1.92 (1.18–3.14) 0.009
Rangpur 474 93.9 2.04 (1.24–3.36) 0.005
Sylhet 1366 82.4 0.59 (0.39–0.91) 0.016
Type of residence
Rural 3570 89.6 1.00 REF
Urban 927 87.0 1.02 0.68–1.53 0.908
aThe dependent variable was coded ‘1’ if child was vaccinated, ‘0’ otherwise
bOR was adjusted for clustering of vaccination of children of the same clusters
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antigens for children receiving the campaign vaccine
[12]. The MR campaign was not explicitly designed to
catch up on other antigens. Findings indicated that some
health workers did use the opportunity for catch up.
Among children aged 9–35 months, 1.3 % lacked the
third dose of pentavalent vaccine compared to 4.2 %
among children aged 36–59 months (data not shown).
This difference could be due to MR campaign. However,
some missed opportunities from the post-campaign sur-
vey remained to be taped. As Bangladesh has high vaccin-
ation coverage, this represents a relatively large fraction
of, and absolute number of, unvaccinated children.
Discussion
Mass vaccination campaigns are considered an import-
ant strategy to increase vaccine coverage. There is on-
going debate, however, regarding the potential for both
positive and negative consequences of mass vaccination
programs, particularly because of the targeted and time-
limited nature of elimination goals and resource con-
straints. Thus, the aim of the present study was to assess
the impact of the measles rubella campaign activities on
improving population-level vaccine coverage and identify
sub-group with lower coverage.
Bangladesh successfully implemented the MR cam-
paign. In post-campaign survey, of the 4510 households
interviewed, 90 % children received MR vaccine during
the campaign. This coverage is high regarding the num-
ber of target population, and consistent with a study
conducted in Albenia [13]. Among different divisions,
Rajshahi and Rangpur had the highest (94 %) and Sylhet
had the lowest (83 %) coverage which were similar to
the results of the EPI coverage evaluation survey [14].
However, coverage of MCV was also increased after im-
plementation of the campaign.
Our study result showed that age, registration prior to
campaign and current school attendance of children were
significantly associated with MR vaccine coverage. The
strategy of inclusion of educational institutes as campaign
centre for giving vaccine to the school children showed
significant positive impact on MR vaccine coverage. The
finding suggests that school-based campaign and delivery
was more successful than the EPI center based campaign
and delivery. As Bangladesh prepares for other potential
school-based vaccine delivery programs, such as HPV, les-
sons from the MR campaign could be applied to achieve
similarly or higher coverage.
The main reasons for non-vaccination during the cam-
paign were sickness of the child, followed by fear of side
effects, which are comparable the finding of another
study [15]. In our study the major benefits of MR cam-
paign according to respondents were opportunity to re-
ceive the vaccine for the children who were not
previously vaccinated, massive publicity to motivate
people to vaccinate their child, opportunity to acquire
knowledge about measles and rubella, reduction of the
fear of vaccination. A study in Uganda showed similar
benefits like provision of second chance to be vaccinated
and positive effect on routine immunization [16].
Our qualitative data showed that the nationwide MR
campaign created positive impact to the society and the
routine immunization system in spite of some limitations.
The campaign increased public awareness of the intended
effects of the vaccine and acceptance during both the cam-
paign and routine EPI sessions. This finding is consistent
with supplementary immunization activity (SIA) and other
campaign to strengthen routine immunization [12, 17].
The campaign has strengthened the vaccine storage as well
as service delivery system. These findings are also con-
sistent with previous measles campaigns in Bangladesh
[17]. The workers involved in the campaign worked be-
yond their designated hours to continue their routine EPI
activities. So routine EPI activities were not hampered or
stopped due to MR campaign which is contrast to experi-
ences in other countries [18]. But the past experience of
campaigns in Bangladesh showed similar findings as well
as some other countries [17].
The main limitation of the study was that the MR vac-
cination information during campaign was collected
through interviewing or history taking. There was no ar-
rangement of providing card to the children/caregivers
during the campaign. Even MR vaccine does not create
any mark on the skin. So we had to completely rely on the
recall of the respondents about the vaccination status of
the children. So we used two-step confirmatory question
to ensure about the vaccination status. Another limitation
was the timing of the survey. We conducted post-
campaign survey about 4 months later to the campaign.
Table 2 Percentage distribution of reasons for not vaccinating children under the MR campaign, by administrative divisions
Reasons for not vaccinatinga Total Barisal Chittagong Dhaka Khulna Rajshahi Rangpur Sylhet
Unaware of campaign 17.11 4.26 19.44 9.52 7.69 7.02 17.86 24.58
Fear of side effects 31.96 40.43 27.78 30.95 35.9 42.11 21.43 29.24
Child was sick 30.52 40.43 38.89 59.52 25.64 17.54 28.57 26.27
Others 22.68 17.02 19.44 0 30.77 36.84 32.14 22.46
n 485 47 36 42 39 57 28 236
aMultiple responses
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This delay was due to antibody detection component [un-
published observations] of this survey. But delay in con-
ducting the survey might have created some recall bias.
The length of the recall period ranged from 4 to 7 months
as survey completed within 3 months from initiation.
Based on the lower coverage observed in traditional
lower performing divisions, such as Sylhet, we re-
commend that the government and partners consider
diverting additional resources to these areas in future
campaigns. This could be in the form of, for example,
increased supervision and monitoring or expanded
demand activities.
This is the first mass campaign of a rubella containing
vaccine and the MR vaccine was only recently intro-
duced into the routine EPI system. Enhancing popula-
tion awareness about rubella disease and its prevention
is an important mechanism for increasing understanding
of the rationale of the MR vaccine over traditional mea-
sles vaccine. We recommend that social mobilization ef-
forts as part of both future campaigns and routine EPI
focus on developing a better understanding of rubella.
Overall, the MR campaign was able to reach high
levels of coverage, however, important differences
existed between different subgroups of the population
defined by geography. We also identified relatively low
levels of interpersonal communication regarding the
campaign through the registration procedure. At the
same time registration was associated with a higher
probability of being vaccinated. We therefore recom-
mend that interpersonal communication through the
registration procedure be a particular area of focus of fu-
ture campaigns, as an approach to reducing inequalities.
While there were a range of positive impacts of the
campaign on the routine EPI system, one area that we
identified as a missed opportunity was the design of the
campaign as a mechanism for catching up children on
other incomplete vaccines. We note, however, that while
the campaign was not designed as an opportunity for
catch-up, some health workers did use the campaign as an
opportunity to identify children who had incomplete vac-
cination schedules. We recommend that future campaigns
be design as the opportunity to catch up on other vaccines.
Conclusions
The results of our evaluation indicated that the cam-
paign was successful in terms of MR coverage and in
improving routine immunization services. The evaluation
provided an important guideline for future evaluation
efforts in Bangladesh and elsewhere.
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